retatrutide clinical trial results weight loss Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Effects of once-weekly subcutaneous retatrutide

These result from its systemic growth-promoting effects

Phentermine for weight loss: Benefits, side effects, and dosage

RusekMPlutaRUlamek-KoziolMCzuczwarSJ.Ketogenic diet in Alzheimers disease

The education level distribution in this study, where 62.8% of participants held a bachelor's degree, was notably higher than in [23], which reported 48% with equivalent education levels, potentially reflecting regional or population-specific differences

These findings urge researchers and clinicians to assess the implications of GSH in promoting chemotherapy resistance and to evaluate the duration of GSH intake during treatment to optimize outcomes